Prostate-specific antigen-based screening: controversy and guidelines

Although prostate-specific antigen (PSA) screening has improved the detection of prostate cancer, allowing for stage migration to less advanced disease, the precise mortality benefit of early detection is unclear. This is in part due to a discrepancy between the two large randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eric H, Andriole, Gerald L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371717/
https://www.ncbi.nlm.nih.gov/pubmed/25857320
http://dx.doi.org/10.1186/s12916-015-0296-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371717/
https://www.ncbi.nlm.nih.gov/pubmed/25857320
http://dx.doi.org/10.1186/s12916-015-0296-5

Ejemplares similares